Summary
- Current Price
- As of today, GILD price is $133.16, down -0.04% in the most recent trading session on
- Current Price All-Time High
- GILD price is currently -15.34% below its historical high of $157.29 set on
- Market Cap
- GILD current market cap is $165B, up +11.33% over the past 365 days
- Revenue
- GILD current annual revenue is $29.45B, up +2.51% year-over-year
- Next Earnings
- The next earnings release for GILD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Gilead Sciences, Inc. |
| Ticker | NASDAQ: GILD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | gilead.com |
| Employees | 17,600 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $133.16 | |
| Price, 1D Change | -0.04% | |
| Market Cap | $165B | |
| TTM Dividend Yield | 2.42% | |
| PE Ratio | - | |
| Beta | 0.35 | |
| Revenue | $29.45B | |
| Revenue, 1Y Change | +2.51% | |
| EPS | $6.78 | |
| EPS, 1Y Change | +1,672.78% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.82 | |
| Next Ex-Dividend | $0.82 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $6.78 | |
| EPS Estimate | -$0.48 | N/A |
| EPS Est. Change | -107.11% | N/A |
| Revenue | $29.45B | |
| Revenue Estimate | $30.67B | N/A |
| Revenue Est. Change | +4.14% | N/A |
| Current Price | $133.16 | |
| Price Target | $160.00 | - |
| Price Tgt. Change | +20.16% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.41 | $0.38 | -91.32% | |
| $8.12 | $6.78 | -16.47% | |
| -$0.48 | N/A | -107.11% | |
| $9.87 | N/A | +45.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $28.30B | $28.73B | +1.49% | |
| $29.20B | $29.45B | +0.84% | |
| $30.67B | N/A | +4.14% | |
| $32.68B | N/A | +10.96% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +11.51% | |
| Price, 3Y | +66.45% | |
| Market Cap, 1Y | +11.33% | |
| Market Cap, 3Y | +65.51% | |
| Revenue, 1Y | +2.51% | |
| Revenue, 3Y | +8.72% | |
| EPS, 1Y | +1,672.78% | |
| EPS, 3Y | +86.36% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $133.16 | |
| SMA 200 | $132.08 | |
| SMA 50 | $129.72 | |
| EMA 200 | $129.17 | |
| EMA 50 | $131.28 | |
| MACD | $0.57 | |
| Beta | 0.35 | |
| ATR | $4.15 | |
| 14-Day RSI | 53.46 | |
| 10-Day Volatility | 30.07% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.82 | |
| Upcoming | $0.82 | |
| Dividend Yield | 2.37% | |
| Total Dividend | $3.16 | |
| Dividends Paid | $4.00B | |
| Payout Ratio | 47.04% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $29.45B | |
| EPS | $6.78 | |
| Gross Profit | $25.52B | |
| Gross Margin | 78.84% | |
| Operating Income | $11.82B | |
| Operating Margin | 40.14% | |
| Net Income | $8.51B | |
| Net Margin | 28.90% | |
| EBITDA | $14.58B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 1.68 | |
| Quick Ratio | 1.53 | |
| - | ||
| Piotroski F-Score | 5 | |
| Altman Z-Score | 4.37 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $22.62B | |
| Cash & Equivalents | $10.61B | |
| Total Assets | $59.02B | |
| Current Assets | $19.89B | |
| Total Liabilities | $36.40B | |
| Current Liabilities | $11.81B | |
| Total Debt | $25.54B | |
| Short Term Debt | $2.91B | |
| Accounts Payable | $715.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $20.93B | |
| Operating Expenses | $13.71B | |
| Cost Of Goods Sold | $3.92B | |
| SG&A | $0.00 | |
| D&A | $2.76B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.29B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $10.02B | |
| CFI | -$4.79B | |
| CFF | -$7.75B | |
| Capex | $563.00M | |
| Free Cash Flow | $10.02B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Needham | → | |
| Cantor Fitzgerald | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| Leerink Partners | → | |
| Morgan Stanley | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| HSBC | → |
Analyst sentiment
Institutional ownership
Screeners with GILD
FAQ
- What is the ticker symbol for Gilead Sciences, Inc.?
- The ticker symbol for Gilead Sciences, Inc. is NASDAQ:GILD
- Does Gilead Sciences, Inc. pay dividends?
- Yes, Gilead Sciences, Inc. pays dividends. The last payment was $0.82, with an ex-dividend date on June 15, 2026
- What sector is Gilead Sciences, Inc. in?
- Gilead Sciences, Inc. is in the Healthcare sector
- What industry is Gilead Sciences, Inc. in?
- Gilead Sciences, Inc. is in the General Drug Manufacturers industry
- What country is Gilead Sciences, Inc. based in?
- Gilead Sciences, Inc. is headquartered in United States
- When did Gilead Sciences, Inc. go public?
- Gilead Sciences, Inc. initial public offering (IPO) was on January 22, 1992
- Is Gilead Sciences, Inc. in the S&P 500?
- Yes, Gilead Sciences, Inc. is included in the S&P 500 index
- Is Gilead Sciences, Inc. in the NASDAQ 100?
- Yes, Gilead Sciences, Inc. is included in the NASDAQ 100 index
- Is Gilead Sciences, Inc. in the Dow Jones?
- No, Gilead Sciences, Inc. is not included in the Dow Jones index
- When was Gilead Sciences, Inc. last earnings report?
- Gilead Sciences, Inc.'s most recent earnings report was on August 4, 2026
- When does Gilead Sciences, Inc. report earnings?
- The next expected earnings date for Gilead Sciences, Inc. is October 29, 2026
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild
